A seasonal flu virus suddenly mutated in the summer. It appears to evade some of our immunity, has kick-started a flu season ...

Figures relating to the H3N2 variant from Australia reveal the country has experienced its worst flu season on record, with ...

He developed extracorporeal membrane oxygenation, or ECMO, a treatment that can sustain patients whose hearts and lungs are ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced that it has entered into a securities purchase agreement with a ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...

Data from Australia indicates that the H3N2 flu strain has caused the country's worst influenza season on record, a trend ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the ...

Announces $6 Million Registered Direct Offering With Concurrent Private Placement Of Warrants. NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing broad-spectrum antiviral ...

NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan SHELTON, CONNECTICUT / ACCESS Newswire / ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from ...